Skip to main content
. 2024 Oct 8;15:348. doi: 10.1186/s13287-024-03958-z

Fig. 3.

Fig. 3

VIP modulates Lgr5-EGFP + progenitor cell number and progeny in vitro. A Experimental outline and treatment scheme. B Quantification of Lgr5-EGFP + progenitor cells in VIP-treated organoids by flow cytometry (n = 10 per group). C Analysis of cellular proliferation following VIP treatment by EdU assay (n = 4 per group). D Flow cytometry analysis of Lgr5-EGFP + cell progeny following VIP treatment (n = 6 per group). E, PCA of transformed count data from bulk RNA sequencing of Lgr5-EGFP + progenitor cells isolated from intestinal control organoids and organoids treated with VIP. F Hallmark gene-set enrichment analysis of differential gene expression in Lgr5-EGFP + progenitor cells isolated from VIP-treated organoids; Ctrl = control, NES = normalized enrichment score. G VIP-induced differential upregulation of hallmark pathways in Lgr5-EGFP + progenitor cells compared to treated whole organoids. *p < 0.05, **p < 0.01. Data are shown as means ± SEM, n = number of biological replicates. Statistical analysis was performed by paired Student’s t-test in (BD)